Skip to search formSkip to main contentSkip to account menu

candoxatril

Known as: 3-(1-((4-carboxycyclohexyl)carbamoyl)cyclopentyl)-2-(2-methoxyethoxymethyl)propanoic acid 5-indanyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
BACKGROUND Endothelin-converting enzyme-1 (ECE-1) processes big endothelin-1 (ET-1) to ET-1, a peptide implicated in atheroma… 
1999
1999
A greatly improved process has been developed for synthesis of the glutarate derivative 2, a key intermediate required for Pfizer… 
1998
1998
AIMS To assess the effect of candoxatril, a novel neutral endopeptidase inhibitor, on exercise capacity, clinical status and… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND Recent studies suggest that neurohumoral mechanisms including decreased renal responses to increases in atrial… 
1994
1994
To study the possible physiological role of atrial natriuretic peptide (ANP) in the regulation of intraocular pressure (IOP) the… 
1991
1991
Basal atrial natriuretic peptide levels and the response to exogenous atrial natriuretic peptide are influenced by dietary sodium…